HRTT — Heart Tronics Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | -979.45% | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2003 | 2004 | 2005 | 2006 | 2007 | 2008E | 2009E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | n/a | n/a | 0.19 | n/a | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Heart Tronics Inc., formerly Signalife Inc., is a medical device company. The Company is engaged in developing and marketing medical devices designed to provide cardiovascular monitoring solutions. The Company provides its cardiovascular monitoring solutions for patients diagnosed with symptoms of heart disease. The company's key product, Fidelity 100, is a heart monitoring system. Fidelity 100 collects undistorted electrocardiogram (ECG) signals in ambulatory patients. The company also has other products, such as Fidelity 300 and other product line extensions, including the Fidelity 200 Event Recording System, Fidelity 350 and Fidelity 400.
Directors
- Last Annual
- December 31st, 2007
- Last Interim
- September 30th, 2008
- Incorporated
- January 19th, 1987
- Public Since
- April 29th, 1997
- No. of Shareholders
- 2,600
- No. of Employees
- 15
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 78,401

- Address
- 14942 Gault St, VAN NUYS, 91405
- Web
- http://www.hearttronics.com
- Phone
- +1 8187822189
- Auditors
- Elliott Davis LLC
Similar to HRTT
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 21:03 UTC, shares in Heart Tronics are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Heart Tronics last closed at $0.00 and the price had moved by -99.86% over the past 365 days. In terms of relative price strength the Heart Tronics share price has underperformed the S&P500 Index by -99.87% over the past year.
There is no consensus recommendation for this security.
Find out moreHeart Tronics does not currently pay a dividend.
Heart Tronics does not currently pay a dividend.
Heart Tronics does not currently pay a dividend.
To buy shares in Heart Tronics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Heart Tronics had a market capitalisation of .
Here are the trading details for Heart Tronics:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: HRTT
Based on an overall assessment of its quality, value and momentum Heart Tronics is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Heart Tronics. Over the past six months, its share price has underperformed the S&P500 Index by -99.85%.
As of the last closing price of $0.00, shares in Heart Tronics were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Heart Tronics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Heart Tronics' management team is headed by:
- Willie Gault - PRE
- Rowland Perkins - CEO
- Jennifer Black - DRC
- Robert Koblin - DRC